Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal

This is a free web portal for the life sciences in North America, Europe and Israel... » read more

DeepCure Closes $24m Series A-1 Led by IAG Capital Partners (2024-04-11)
Series A-1 financing will advance programs in immunology and inflammation, and expand AI and automation capabilities for small molecule drug discovery DeepCure, a leader in developing novel, small molecule therapeutics powered by AI and automation of chemistry...
FundaMental Appoints Dirk Beher as CEO & Adds Investor NVF (2024-04-11)
> Highly experienced biotech executive, with over a quarter of a century of CNS drug discovery experience > Dr. Beher takes over the role of Chief Executive Officer from co-founder Dr. Thomas Schulze > FundaMental Pharma recently raised additional seed fundin...
Orgenesis & Germfree: Asset Purchase & Strategic Partnership (2024-04-10)
Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (Nasdaq: ORGS), a global leader in decentralizing cell and gene therapies (CGTs), today announced an asset purchase and strategic partnership aimed at advancing Orgen...
Vertex to Acquire Alpine Immune Sciences for $4.9b in Cash (2024-04-10)
- Alpine is a clinical stage biotechnology company focused on discovering and developing innovative, protein-based immunotherapies - - Alpine’s lead product, povetacicept, demonstrated best-in-class potential in patients with IgA nephropathy (IgAN); Phase 3 to...
Seaport Therapeutics Launches with $100m Series A Financing (2024-04-09)
> Daphne Zohar, Founding CEO of PureTech Health and Co-Founder of Karuna Therapeutics, is Founder, Chief Executive Officer and Member of the Board of Directors of Seaport > Steven M. Paul, M.D., former CEO and Chair of Karuna Therapeutics, President of Lilly Res...
Boehringer Ingelheim BioChina Able to Supply EU & US Markets (2024-04-09)
Boehringer Ingelheim Biopharmaceuticals China (BioChina), in collaboration with a customer, has successfully passed pre-approval inspections by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). As a result, the customer is now...
Basilea: FDA Approves Antibiotic Zevtara in 3 Indications (2024-04-04)
Ad hoc announcement pursuant to Art. 53 LR Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the US Food a...
EnteroBiotix Completes £27m Financing Round (2024-04-04)
EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today announced that the Company has completed its £27m ($34m USD) funding round, supported by new and existing investors. The ...
Biognosys and Alamar Biosciences Forge Strategic Partnership (2024-04-04)
> Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomics > Complementary value of Biognosys’ DIA-MS unbiased proteomics platform and Alamar’s game-changing imm...
Genmab to Acquire ProfoundBio for $1.8b in Cash (2024-04-03)
> Genmab to acquire ProfoundBio for USD 1.8 billion in cash > Acquisition will give Genmab worldwide rights to three candidates in clinical development, including rinatabart sesutecan (Rina-S), plus ProfoundBio’s novel antibody-drug conjugate (ADC) technology ...

Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!

[LSUS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the North America, Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!

» Start here with the latest News!

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]